Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
2022 · Journal of Translational Medicine · 58 citations
https://doi.org/10.1186/s12967-022-03807-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1
Papers
58
Citations
1
h-index
1
i10-index
Yachan Luo is an academic researcher from The Affiliated Yongchuan Hospital of Chongqing Medical University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Inflammatory mediators and NSAID effects & Immune cells in cancer. The author has an h-index of 1, co-authored 1 publications.
Click to start Chat